Key result
Glycosaminoglycans bind factor Xa in a charge- and calcium-dependent manner, inducing conformational changes that modulate its catalytic activity and ability to activate factor VII.
Glycosaminoglycan binding to factor Xa is Ca2+-dependent and charge-dependent, perturbing exosites and modifying its catalytic activity and interactions with cofactors.
May guide anticoagulant development; leaves open translation of glycosaminoglycan–factor Xa interactions to human thrombosis.
Recent studies have demonstrated the existence of a Ca(2+)-dependent heparin-binding site on factor Xa. To characterize this heparin-binding site, the extrinsic fluorescence of fluorescein-labeled, active site-blocked factor Xa was monitored as it was titrated with glycosaminoglycans of various sulfate content and chain length. The binding of glycosaminoglycans to factor Xa appears to be charge-dependent because affinity is correlated with degree of glycosaminoglycan sulfation. All glycosaminoglycans bind factor Xa with higher affinity in the presence of Ca(2+) than in its absence. In contrast, when Gla-domainless factor Xa was substituted for factor Xa, glycosaminoglycans bound with similar affinities in the absence and presence of Ca(2+). These results support the hypothesis that the anionic Gla domain impairs glycosaminoglycan binding in the absence of Ca(2+). The changes in fluorescence intensity of factor Xa when titrated with glycosaminoglycans suggest that glycosaminoglycans induce conformational changes in the active site environment of factor Xa. To explore the consequences of these conformational changes, the effect of glycosaminoglycans on the catalytic activity of factor Xa was examined. Glycosaminoglycans influenced the ability of factor Xa to cleave chromogenic substrates and attenuated the capacity of factor Xa to activate factor VII. The potency of glycosaminoglycans in these assays reflected their affinity for factor Xa. These studies suggest that glycosaminoglycan binding perturbs exosites on the surface of factor Xa, potentially modifying interactions with cofactors or substrates.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2003) studied this question. Glycosaminoglycans vs. Absence of Ca2+ / Gla-domainless factor Xa was evaluated on Binding affinity and catalytic activity of factor Xa. Glycosaminoglycans bind factor Xa in a charge- and calcium-dependent manner, inducing conformational changes that modulate its catalytic activity and ability to activate factor VII.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: